IN181289B - - Google Patents

Info

Publication number
IN181289B
IN181289B IN670CA1995A IN181289B IN 181289 B IN181289 B IN 181289B IN 670CA1995 A IN670CA1995 A IN 670CA1995A IN 181289 B IN181289 B IN 181289B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Rudolf Edgar Falk
Samuel S Asculai
Eva Anne Turley
Original Assignee
Norpharmco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norpharmco Inc filed Critical Norpharmco Inc
Publication of IN181289B publication Critical patent/IN181289B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN670CA1995 1992-09-25 1995-06-13 IN181289B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002079205A CA2079205C (fr) 1992-09-25 1992-09-25 Utilisation de l'acide hyaluronique et de formules pour empecher la restenose arterielle

Publications (1)

Publication Number Publication Date
IN181289B true IN181289B (fr) 1998-05-02

Family

ID=4150463

Family Applications (1)

Application Number Title Priority Date Filing Date
IN670CA1995 IN181289B (fr) 1992-09-25 1995-06-13

Country Status (26)

Country Link
EP (1) EP0661981B1 (fr)
JP (1) JP3742955B2 (fr)
CN (1) CN1057908C (fr)
AP (1) AP448A (fr)
AT (1) ATE141054T1 (fr)
AU (1) AU670117B2 (fr)
BR (1) BR9307221A (fr)
CA (1) CA2079205C (fr)
CZ (1) CZ288986B6 (fr)
DE (1) DE69303931T2 (fr)
DK (1) DK0661981T3 (fr)
ES (1) ES2091031T3 (fr)
GR (1) GR3021171T3 (fr)
HK (1) HK35397A (fr)
HU (2) HU227067B1 (fr)
IL (1) IL107087A0 (fr)
IN (1) IN181289B (fr)
MD (1) MD960294A (fr)
MX (1) MX9305887A (fr)
NO (1) NO309457B1 (fr)
NZ (1) NZ255978A (fr)
PL (1) PL308201A1 (fr)
SG (1) SG48845A1 (fr)
SK (1) SK36895A3 (fr)
TW (1) TW271401B (fr)
ZA (1) ZA937068B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1999010385A1 (fr) * 1997-08-22 1999-03-04 Denki Kagaku Kogyo Kabushiki Kaisha Gel d'acide hyaluronique, son procede de production et substance therapeutique le contenant
FR2813791B1 (fr) 2000-09-14 2004-03-12 Lafon Labor Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (fr) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Traitement de maladies et d'etats pathologiques

Also Published As

Publication number Publication date
GR3021171T3 (en) 1996-12-31
AU670117B2 (en) 1996-07-04
HU211698A9 (en) 1995-12-28
EP0661981B1 (fr) 1996-08-07
CA2079205C (fr) 1998-02-10
BR9307221A (pt) 1999-07-27
DE69303931T2 (de) 1997-01-09
ATE141054T1 (de) 1996-08-15
JPH08506797A (ja) 1996-07-23
SK36895A3 (en) 1997-03-05
CN1092654A (zh) 1994-09-28
CN1057908C (zh) 2000-11-01
MX9305887A (es) 1994-05-31
DK0661981T3 (da) 1996-12-23
MD960294A (ro) 1997-10-31
ZA937068B (en) 1994-04-18
AP9300568A0 (en) 1993-10-31
JP3742955B2 (ja) 2006-02-08
EP0661981A1 (fr) 1995-07-12
HUT73637A (en) 1996-08-28
AU4812693A (en) 1994-04-26
CZ66295A3 (en) 1996-02-14
ES2091031T3 (es) 1996-10-16
NO951122L (no) 1995-03-23
NZ255978A (en) 1997-02-24
DE69303931D1 (de) 1996-09-12
AP448A (en) 1996-01-18
HK35397A (en) 1997-03-27
NO951122D0 (no) 1995-03-23
TW271401B (fr) 1996-03-01
PL308201A1 (en) 1995-07-24
CA2079205A1 (fr) 1994-03-26
IL107087A0 (en) 1993-12-28
NO309457B1 (no) 2001-02-05
HU227067B1 (en) 2010-06-28
HU9500857D0 (en) 1995-05-29
CZ288986B6 (cs) 2001-10-17
SG48845A1 (en) 1998-05-18

Similar Documents

Publication Publication Date Title
TW224162B (fr)
DK0652790T3 (fr)
DK0553875T3 (fr)
DK0554977T3 (fr)
DK0625187T3 (fr)
DK135092A (fr)
TW271401B (fr)
DK148492D0 (fr)
DK0564197T3 (fr)
TW235313B (fr)
DK0571172T3 (fr)
DK0597323T3 (fr)
BR9202713C1 (fr)
TW229341B (fr)
DE9207553U1 (fr)
DK137892D0 (fr)
DK127492D0 (fr)
IN181079B (fr)
IN176966B (fr)
IN173460B (fr)
DK150392D0 (fr)
DK11192D0 (fr)
BR9304980A (fr)
BRPI9204323A2 (fr)
CN3014437S (fr)